A Clinical Study to Investigate the Efficacy of Intratumoral Tigilanol Tiglate in Soft Tissue Sarcoma
Clinical trial NCT05755113 · RECRUITING
Trial details
- NCT number
- NCT05755113
- Sponsor
- QBiotics Group Limited
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-13
- Primary completion
- 2027-01-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.